| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 135k | $7.78 | $1.1M | | 01/03/2023 |
| 03/01/2022 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 117.4k | $13.41 | $1.6M | | 03/01/2022 |
| 06/23/2021 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 113.3k | $19.00 | $2.2M | | 04/12/2021 |
| 04/12/2021 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 387.1k | $0.00 | $0 | | 04/12/2021 |
| 09/14/2020 | Fulcrum Therapeutics, Inc. | FULC | Exercise | Stock Option (right to buy) | 6.4k | $7.84 | $49.8k | | 09/14/2020 |
| 06/30/2020 | Fulcrum Therapeutics, Inc. | FULC | Sale | Common Stock | 141 | $20.00 | $2.8k | | 06/30/2020 |
| 06/30/2020 | Fulcrum Therapeutics, Inc. | FULC | Exercise | Stock Option (right to buy) | 141 | $7.84 | $1.1k | | 06/30/2020 |
| 05/28/2020 | Fulcrum Therapeutics, Inc. | FULC | Sale | Common Stock | 2.2k | $20.00 | $44.6k | | 05/28/2020 |
| 05/28/2020 | Fulcrum Therapeutics, Inc. | FULC | Exercise | Stock Option (right to buy) | 2.2k | $7.84 | $17.5k | | 05/28/2020 |
| 05/27/2020 | Fulcrum Therapeutics, Inc. | FULC | Exercise | Stock Option (right to buy) | 448 | $7.84 | $3.5k | | 05/27/2020 |
| 05/27/2020 | Fulcrum Therapeutics, Inc. | FULC | Sale | Common Stock | 448 | $20.00 | $9k | | 05/27/2020 |
| 05/26/2020 | Fulcrum Therapeutics, Inc. | FULC | Exercise | Stock Option (right to buy) | 412 | $7.84 | $3.2k | | 05/26/2020 |
| 05/26/2020 | Fulcrum Therapeutics, Inc. | FULC | Sale | Common Stock | 412 | $20.00 | $8.2k | | 05/26/2020 |
| 02/19/2020 | Fulcrum Therapeutics, Inc. | FULC | Exercise | Stock Option (right to buy) | 6.1k | $7.84 | $47.7k | | 02/19/2020 |
| 02/19/2020 | Fulcrum Therapeutics, Inc. | FULC | Sale | Common Stock | 6.1k | $20.00 | $121.8k | | 02/19/2020 |
| 01/23/2020 | Fulcrum Therapeutics, Inc. | FULC | Grant | Stock Option (right to buy) | 58.9k | $16.87 | $993.6k | | 01/23/2020 |
| 07/18/2019 | Fulcrum Therapeutics, Inc. | FULC | Grant | Stock Option (right to buy) | 44.5k | $16.00 | $711.9k | | 07/18/2019 |